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Background - It is difficult to non-invasively phenotype atrial fibrillation (AF) in a way that 
reflects clinical endpoints such as response to therapy. We set out to map electrical patterns of 
disorganization and regions of reentrant activity in AF from the body surface using 
electrocardiographic imaging (ECGI), calibrated to panoramic intracardiac recordings and 
referenced to AF termination by ablation.     
Methods - Bi-atrial intracardiac electrograms of 47 AF patients at ablation (30 persistent, 29 
male, 63±9 years) were recorded with 64-pole basket catheters and simultaneous 57-lead body 
surface ECGs. Atrial epicardial electrical activity was reconstructed and organized sites were 
invasively and non-invasively tracked in 3D using phase singularity (PS).  In a subset of 17 
patients, sites of AF organization were targeted for ablation. 
Results - Body surface mapping showed greater AF organization near intracardially-detected 
drivers than elsewhere, both in PS density (2.3±2.1 vs 1.9±1.6, p=0.02) and number of drivers 
(3.2±2.3 vs 2.7±1.7, p=0.02). Complexity, defined as the number of stable AF reentrant sites, 
was concordant between non-invasive and invasive methods (r2 =0.5, CC=0.71).  In the subset 
receiving targeted ablation, AF complexity showed lower values in those in whom AF 
terminated than those in whom AF did not terminate (p<0.01).  
Conclusions - AF complexity tracked non-invasively correlates well with organized and 
disorganized regions detected by panoramic intracardiac mapping, and correlates with the acute 
outcome by ablation. This approach may assist in bedside monitoring of therapy or in improving 
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Nonstandard Abbreviations and Acronyms 
AF Atrial Fibrillation 
DF Dominant Frequency 
ECGI Electrocardiographic Imaging 
EGM Electrogram 
HDF Highest Dominant Frequency 
icEGM Inverse-computed Electrogram 
LA Left Atrium 
PS Phase Singularity 
PVI Pulmonary Vein Isolation 






There is great interest in improving therapies for atrial fibrillation (AF) due to the suboptimal 
outcomes of current pharmacological and interventional approaches. In the case of ablation, 
pulmonary vein isolation (PVI) success rarely exceeds 50-70% in patients with persistent or 
paroxysmal AF1. New approaches have been developed based on the identification and 
elimination of atrial regions2-6 including reentrant or focal drivers2 or fastest regions4 evaluated 
by intracardiac electrograms. Guiding ablation to localized drivers may improve success in meta-
analyses7-8, and trended to be superior to PVI in subgroups of a recent randomized trial9 except 
when also combined with ablation of lines or complex electrograms. Clearly, improved methods 
of detecting sites for AF ablation are needed. 
We hypothesized that body surface mapping can detect relevant features of intracardiac 
organization and disorganization in AF, with the ultimate goal of guiding bedside management 
or ablation.  Non-invasive tools have the potential to supplement intracardiac AF mapping3,6. 
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electrical activity and characterization of the fibrillatory process3. This technique has been used 
to localize atrial regions causing arrhythmia by identifying electrical reentries, shown as 
singularities in non-invasive phase maps, which can successfully guide ablation3.  While phase 
maps may code any rotational activation as a singularity, this can be clarified by examining 
activation sequence10. In AF mapping, the severity has been linked to the number of ablated 
regions needed to terminate AF, suggesting that non-invasive metrics may be useful to 
characterize AF and identify ablation targets. Nevertheless, few studies have validated body 
surface metrics against intracardiac measures. 
The purpose of this paper was to compare functional AF features between non-invasive 
phase mapping and panoramic intracardiac phase and activation mapping with a basket-type 
catheter. To achieve this, we recorded simultaneous intracardiac and non-invasive electrograms 
and applied phase mapping in patients undergoing ablation including a subset with targeted 
ablation at localized reentrant drivers. We reasoned that, for consistent comparison between 
intracardiac and body surface sources to be consistent, the same source identification method 
should be used in both cases. Therefore, we opted to analyze only reentrant sources, which 
comprise > 80% of sources in several studies2-3 and can be measured by parallel approaches. 
 
Methods 
All code is publicly available at https://www.ncbi.nlm.nih.gov/pubmed/27790158.  
Inclusion Criteria 
We recruited 47 patients referred for AF ablation in two centers: Hospital General Universitario 
Gregorio Marañón (HGUGM, Madrid, Spain, N=30) and Stanford Hospital (SH, CA, USA, 
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received conventional Pulmonary Vein Isolation (PVI) ablation, whereas patients from the SH 
received prospective ablation at regions of interest (rotational or focal sites) identified by a 
commercial system (RhythmView; Abbott, Inc), followed by conventional PVI ablation. In this 
paper, analysis focused on detecting reentrant activity by an open-source algorithm11. The 
protocol was approved by each local Institutional Ethics Committees and all patients gave 
informed consent. The goal of this study was to correlate non-invasive to invasive AF mapping 
in a variety of patients. Patient’s demographics are presented in Table 1, where significant 
difference between PVI and driver-guided ablation cohort can be found in persistent/ 
paroxysmal, male/female distribution, AF history and number of previous ablations. Also, a 
subset of the PVI ablation cohort (N=13, 28%) was derived from a mitral valvuloplasty 
procedure that was performed prior to the AF ablation procedure.  
Electrophysiological Study and Ablation 
Classes I and III antiarrhythmic medications were discontinued for >5 half-lives (>30 days for 
amiodarone). Catheters were advanced to the right atrium (RA), coronary sinus, and transeptally 
to left atrium (LA). In patients arriving in sinus rhythm, AF was induced using electrical burst 
pacing. Contact basket catheters (64 poles) were positioned in RA, then LA for AF mapping, 
based on 3-dimensional electroanatomic imaging (NavX, St Jude Medical). In 22 patients of the 
PVI ablation cohort, 2 basket catheters were simultaneously positioned at LA and RA.  
Radiofrequency energy was delivered via an irrigated catheter (Cool-Flex 
/TactiCath/Sapphire-Blue, St Jude Medical) at 25 to 35 W. In patients undergoing driver-guided 
ablation, lesions were applied for 15 to 30 s at each site identified by the RhythmView system, 
successively, to cover areas of 2 to 3 cm2 as described by Miller et al12. An example of the lesion 
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circumferential point-by-point ablation or cryoablation of left and right PV pairs (Artic Front, 
Medtronic Inc.) with verification of PV isolation using dedicated circular mapping catheters. 
Data Acquisition 
Unipolar electrograms (EGM) from basket catheters were recorded with 0.05 to 500 Hz bandpass 
filtering, at 1 kHz sampling prior to the ablation protocol. Raw electrograms from 64 basket and 
other intracardiac channels (eg, coronary sinus) and 12-lead ECG were exported from Bard 
(LabSystem Pro), Prucka (GE Cardiolab) or Boston Scientific (ClearsignTM) recorders for off-
line analysis. Basket electrode positions and atrial anatomy meshes were extracted from the 
electro-anatomical navigation system (Ensite NavX System) that enabled atrial anatomy 
reconstruction. Figure 1.A shows a single basket position snapshot, of the 2-3 used for mapping 
each chamber13. 
CT images were acquired 2-3 days prior to the ablation procedure. Atria and torso 
anatomy were obtained by segmentation of CT images by using ITK-SNAP14 (Fig. 1.B). 
Additionally, the torso anatomy, together with the surface electrode location was obtained by 
two techniques, depending on the ablation protocol. In patients derived for conventional PVI 
ablation, photographic images from multiple points of view were obtained for each patient 
wearing the recording electrodes and torso images were processed by photogrammetry to 
reconstruct the torso anatomy with the surface electrode positions15. In patients undergoing 
driver-guided ablation, fluoroscopy images of the surface electrodes were recorded during the 
Electrophysiological study and processed to identify and co-register the electrode positions in the 
torso anatomy. Anatomical models obtained with the different technologies were co-registered 
by using an algorithm based on rigid transformations guided by fiducial points manually marked 
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or torso models (anterior and posterior axillae, nipples, low scapula and xiphoid appendix)16 
(Fig. 1.D). 
Multichannel electrocardiograms (ECGI) were recorded with surface ECG leads during 
the electrophysiological study6. Signals were acquired simultaneously with intracardiac 
recordings on the commercial with 0.05 to 500 Hz bandpass filtering at 1 kHz sampling 
frequency and were exported for off-line analysis. 57 surface electrodes were distributed as 
follows: 24 electrodes on the anterior, 24 on the posterior, 3 on each lateral side of the torso and 
3 extra leads in order to obtain a Wilson Central Terminal (Figure 1.C).  
Data Management 
Simultaneous intracardiac and body surface signals from 160 AF episodes (3.4 ± 1.8 per patient) 
with an average duration of 4.9 ± 1.4 seconds were used for the reentrant activity analysis.  
For intracardiac signal analysis, first the average QRS complex was computed and 
subtracted for each of the electrogram channel. Next, intracardiac atrial signals were baseline-
subtracted6, 17 and low-pass filtered with a 10th-order Butterworth filter with a cut-off frequency 
of 20 Hz. Intracardiac signals were then prepared for phase analysis by a 2 Hz bandwidth elliptic 
band-pass filter centered at the Highest Dominant Frequency (HDF) of each basket catheter18, 
obtained as the 95th percentile of the dominant frequencies (DF) of the basket signals. Then, 
intracardiac basket signals were interpolated in a 1026-node mesh created by using the location 
of the 64 basket electrodes (Figure 2.A) and phase filtered using the Hilbert transform. Phase 
singularities (PS) (> 1 rotation) were then detected in this 3D phase mesh as described in our 
previous works19.  
For the body surface analysis, a QRST removal algorithm was applied to each ECG 
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posterior filtering with a Butterworth 10th-order low-pass filter with a cut-off frequency of 2 Hz. 
This signal was interpolated to the sample frequency and subtracted from the original signal. 
Surface signals were then low-pass filtered with a 10th-order Butterworth filter with a cut-off 
frequency of 20 Hz. We estimated the inverse-computed epicardial signals, or non-invasive 
signals, by applying the zero-order Tikhonov’s method on the filtered surface ECG signals over 
the torso and atrial anatomy. The optimal regularization parameter was chosen at the first local 
maximum value of the curvature of the L-curve21. Finally, non-invasive signals on the atrial 
mesh were phase-transformed using the Hilbert method, and stable PS (> 1 rotation) were then 
detected in the 3D phase mesh and considered as rotational activity sites19 (Figure 2C). 
Statistical Analysis 
Continuous data are represented as mean ± SD. Normality was evaluated using the Kolmogorov–
Smirnov test. Comparisons between 2 groups were made with Student t tests for independent 
samples if normally distributed, or if not normally distributed, with the Mann–Whitney U test. 
Nominal values were expressed as n (%) and compared with χ2 tests. Paired t test was used for 




Individual reentrant activity identification 
In order to assess the ability of body surface mapping to identify localized reentrant activity 
during AF episodes, we analyzed non-invasive phase signals at the location of the reentrant 
patterns detected by intracardiac mapping. Figure 2A shows the phase map of the intracardiac 
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phase map of the intracardiac signals showed a stable phase singularity (Panel A) in the anatomic 
position close to lateral Superior Vena Cava (SVC) and Right Atrial (RA) junction. The reentrant 
activity could also be observed in the individual intracardiac signals surrounding this location, 
marked as #1-#6 in Panel A and depicted in Panel B. These six intracardiac signals (blue) 
showed consecutive phase evolutions (gray signals) verified by consecutive activation 
sequences, from #1 to #6, corresponding to reentry identified in the phase map. Non-invasive 
signals were analyzed during the same time interval as Panels A-B, and the corresponding phase 
map is depicted in Panel C. In this case, a phase singularity could be observed in the RA wall, 
marked with an arrow, at 17 mm from the intracardially-detected reentry from Panel A. This 
non-invasive reentrant activity could also be observed on the sequence of non-invasive signals 
(Panel D) surrounding the phase singularity location, marked from #1 to #6 in the figure. Both 
non-invasive signal traces (blue) and the corresponding phase transform (grey) confirm the 
reentrant activity in the RA.  
Reentrant activity measurements 
A systematic comparison between intracardiac and non-invasively detected reentries is depicted 
in Figure 3. Reentrant activity detected at phase maps from both intracardiac and body surface 
recordings is summarized in spatial histograms, showing a summation of reentrant activity (PS) 
detected in each atrial region. For an individual AF episode with two basket catheters, one in 
each atrium, the intracardiac phase map (Panel A) showed the presence of reentrant activity in 
the antrum of the left pulmonary veins and at the roof of the right atria (marked with red colors). 
For the same episode, the non-invasive reentrant map (Panel B), also showed reentrant activity in 
antrum of the left pulmonary veins and the superior vena cava antrum, as well as in the right 
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To systematically compare the presence of intracardiac and non-invasive reentries, the 
number of body surface reentries were compared with the number of intracardiac AF sources 
(Fig. 3C). We made this comparison in atrial regions mapped by intracardiac mapping,  which 
mapped 77.4 ± 15.6 % of each atrium (Fig 3.C), similar to recent analyses using new basket 
designs22. For this purpose, reentrant intracardiac and non-invasive activity was measured as the 
number of reentrant sites in the histogram. Specifically, regions with >10% of overall reentrant 
activity (sources) were marked as intracardiac reentry regions. The number of observed body 
surface AF sources correlated with the number of intracardiac reentrant sources (R2=0.50, 
CC=0.71, p<0.01).  
Measurements of the presence of reentrant activity were used to discriminate patients 
with low and high reentrant activity. In Panels D and E, the patient cohort was separated by the 
median (50th percentile) of patients with lower versus higher reentrant intracardiac and non-
invasive drivers, respectively. In panel D, patients were separated by the presence of low or high 
intracardiac reentry activity, thresholded by the median number of intracardiac sources (6.1).  
These groups differed in body surface reentrant activity measures (4.2±1.5 vs 7.1±1.6, p<<0.01). 
Panel E shows patients separated by low and high non-invasive rotor presence thresholded by the 
median number (5.9) of body surface sources, which also showed differences in intracardiac 
reentrant activity presence: 3.7 ± 2.1 vs 7.8 ± 1.6, p<<0.01. 
Local comparison of body surface and intracardiac reentrant activity 
Colocalization of intracardiac and body surface AF reentrant sites was systematically measured 
for the whole cohort (Fig. 4). The presence of non-invasive individual phase singularities and 
stable rotors was measured at the atrial regions where the intracardiac mapping showed stables 
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was detected covered 16.5 ± 8.8 % of the atrial anatomy.  Remaining atrial regions mapped by 
the basket, with no detected intracardiac reentries, represented 35.5 ± 17.0 % of atrial anatomy 
(p<<0.01). The sum of both areas (52.0 ± 15.7%, reentry regions + rest) did not cover the entire 
atrial area due to the lack of basket placement in both atria and some anatomical regions not 
covered by baskets (brown regions in Figure 3.A).  
Reentry activity in AF detected non-invasively was higher at regions identified as 
reentrant sites than at regions not identified as reentrant sites on intracardiac maps (2.3±2.1 vs 
1.9±1.6 PSs per mm2; p=0.017, Fig. 4.A) when considering individual phase singularity density, 
and 3.2±2.3 vs 2.7±1.8 reentrant sites (p=0.015, Fig. 4.B) . 
Finally, we performed a detailed comparison of reentrant sources in the posterior LA 
wall, which were also regions best mapped by basket catheters. As observed in Figure S2, the 
proportion of reentrant sources detected by intracardiac and body surface mapping was similar, 
mostly being at the left PVs (42% vs 47% of sources) and the LA roof (27% vs. 19%).  
Body surface reentrant activity and impact of ablation  
Non-invasive reentry mapping measurements were compared with acute clinical outcomes of 
ablation, and AF terminated during the ablation protocol in 41% of the guided-ablation cohort 
(Table S1). 
Figure 5.A-B shows the body surface reentrant activity maps for representative patients 
in whom driver-guided ablation did and did not acutely terminate AF, respectively. Overall, 
patients in whom driver-guided ablation acutely terminated AF during the procedure (N=7, 
figure 6.A), had less global non-invasive reentrant regions (5.8 ± 3.1) than those in which AF did 
not terminate (N=10, 9.8 ± 4.5, p<0.001). We observe that this parameter can be a reasonable 
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curve of 0.88 (see Figure S3), with a specificity of 85.7% and a sensitivity of 80.0% when using 
a threshold of 7.5 body surface drivers. 
To evaluate reentrant activity presence based on the classical AF classification 
(paroxysmal and persistent), we performed a similar analysis dividing the cohorts using this 
criterion (Figure 6.B). No significant differences were seen between paroxysmal and persistent 
patients in terms of reentrant activity in non-invasive maps. Body surface reentrant measures 
predicted AF termination better than the classical classification of paroxysmal/persistent AF (Fig 
6.C; 85.7% vs. 80.0%; p=0.76). Moreover, none of the demographic or clinical parameters were 
statistically significant for acute termination (paroxysmal/persistent AF p=0.76, sex p=0.32, age 
p=0.91, history of AF p=0.90, see Supplemental Table S2) except that the number of previous 
ablations was higher in the termination group (p=0.02). 
Driver-guided ablation by Electrocardiographic Imaging and intracardiac mapping 
Finally, we analyzed the possible ability of body surface mapping to extend atrial mapping 
beyond what was possible by baskets, and thus potentially improve the success of AF ablation. 
We studied the number of AF reentrant sites detected on the body surface maps outside of sites 
mapped by baskets in the driver-guided ablation cohort (Figure 7). Panel A shows a schematic 
figure in one patient in whom the driver-guided ablation did not terminate AF, where the basket-
mapped regions are green (all 4 basket positions and episodes are shown) and non-mapped 
regions are brown. The non-invasive map (Panel B) showed higher reentrant activity in locations 
that were not mapped intracardiac (left superior pulmonary vein and superior vena cava).  
In the entire driver-guided-ablation cohort (N=17), there were fewer non-invasively 
identified driver sites outside basket-mapped regions (Panel C) in patients in whom ablation 
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Discussion 
The present study performed simultaneous body surface and intracardiac recordings in a large 
population of patients with different AF types. We calibrated non-invasive mapping to basket 
intracardiac recordings of AF, and correlated reentrant activity based on simultaneous 
recordings. The correlation between ‘overall’ reentrant measurements between intracardiac and 
body surface mapping techniques showed good correspondence between number of potential 
driver sites, with a positive though modest correlation on individual comparisons in terms of 
exact anatomical position.   
Identification of AF drivers  
Most methods to map AF electrical activity and substrates require the introduction of catheters 
inside the heart that enable localization of sites maintaining the arrhythmia. While baskets do not 
contact the entire atrial surface, Honarbaksh et al reported that current baskets map 70-80% of 
the atrial surface22 which agrees with our coverage of 77.4 ± 15.6% per basket position. 
Moreover, current practice further increases mapped area by moving the basket to multiple 
positions.. Recent results of the REAFFIRM trial showed no benefit of driver ablation over PVI 
by intention to treat analysis yet, due to multiple off-protocol ablations, on-treatment analysis of 
PVI+driver ablation provided success of 77.8% which trended higher than PVI alone (65.5%; 
p=0.09)9.  This benefit was eliminated in patients in whom complex fractionated electrograms 
and lines were also ablated9. 
Ablation was guided by a clinical FDA- approved system (RhythmViewTM). To enable 
others to reproduce our work, all analyses in our study were performed using open-software 
algorithms (phase analysis; http://narayanlab.stanford.edu). For illustration, we show 
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system, which uses activation mapping for gray-scale movies and phase densities plotted in red, 
at the expense of a lower specificity. Nevertheless, 93% of the AF sources shown by 
RhythmViewTM were also identified by our open source phase mapping.  
Noninvasive mapping provides high resolution simultaneous recording of biatrial AF 
activation sequences. Haissaguerre et al.3 used this technique in 103 persistent AF patients to 
guide the ablation procedure, showing acute termination rate of 75% for persistent and 15% for 
long-standing AF patients, and showing also the relation between the number of targeted regions, 
the degree of AF progression and the probability of AF termination. These results have been 
confirmed by a multicenter trial demonstrating that non-invasive identification and ablation of 
drivers resulted in high rates of persistent AF termination and favorable AF-free survival at 1 
year23. Despite these promising results, few prior studies systematically evaluated 
correspondence of noninvasive maps with intracardiac recordings: only AF cycle length3 and 
regional reentrant activity during sequential mapping has been studied24. 
Body surface cardiac mapping 
Electrocardiographic Imaging has been used as an independent technique to non-invasively map 
electrical activity of the whole epicardium simultaneously. However, several methodologic 
questions have emerged. Duchateau et al. showed that the correlation of classical 
electrophysiological measurements, such as activation time mapping, appear to diverge between 
body surface and catheter-based recordings25. The methodologic limitations (i.e. bipolar vs. 
unipolar recordings) together with the biophysical limitations of the inverse resolution, prevent 
that signals reconstructed by non-invasive mapping had temporal and/or spatial precision to 
enable accurate calculation of local activations and to reproduce isochronal maps19,21,26. 
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phase can still be used in body surface cardiac mapping when local activation times are not 
achievable. These parameters are intrinsically more stable than activation times, since they do 
not depend on a single fiducial point. Both frequency and phase mapping summarize a series of 
temporal and spatial voltage distributions in a single measure (DF, singularity point) and 
therefore they should be intrinsically more robust against the biophysical limitations of the 
inverse problem18. On the other hand, phase analysis can be applied to intracardiac and non-
invasive signals, which is important for this comparison of both mapping techniques. While 
FIRM includes activation (gray-scale movies) as well as phase (red marked regions), body 
surface signals are best analyzed by phase.  We thus use phase for intracardiac and body surface 
analysis, while accepting that this is not free of controversy due to the risk of detecting false 
reentries27. Other methodologies for intracardiac mapping not based on phase analysis have also 
been proved useful for AF driver identification28, although their extrapolation to non-invasive 
signals is still under debate.  
Prior studies have evaluated the electrical complexity of AF, demonstrating that most 
paroxysmal AF drivers are located close to the PV antrum while persistent AF patients have a 
more evenly-spaced distribution of drivers outside the PV antra to the body of the atria4,8. In 
agreement with these results, Lim et al. noninvasively mapped persistent AF and found a higher 
number of re-entrant drivers and dispersion outside the PVs with increasing AF duration29. 
However, these results have been restricted to patients presenting with persistent AF1. Here, we 
found that the number of reentrant activity regions was inversely related to the severity of AF 
across clinical labels of paroxysmal, persistent and longstanding persistent AF, and with the 
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Clinical implications of body surface mapping in AF 
The main application of non-invasive mapping thus far has been to guide and plan AF ablation, 
specifically to identify regions that harbor drivers outside the PVs. This approach has been 
tested3,23. To date, such noninvasive methods have been applied only to patients referred for 
ablation, which actually represent a small fraction of AF patients (<2%)30. Characterization of 
fibrosis in the atrial substrate has been also used to non-invasively predict ablation success31.  
The current study reveals that body surface mapping may be suitable to map and 
distinguish AF mechanisms relevant to ablation, but may be applied in general AF management. 
Here we present noninvasive results that non-invasive mapping may help to distinguish patients 
in whom ablation can terminate AF better than clinical AF labels of paroxysmal and persistent 
AF. Therefore, this noninvasive technology may help distinguish which patients are more 
suitable for ablation. Moreover, this body surface approach may help personalize broader 
strategies including drugs for individual AF patients, depending on their substrates. More 
evidence in general AF populations with inclusion of other common AF therapeutic options 
(rate/rhythm control, cardioversion, etc.) are needed to advance in the therapy individualization 
based on noninvasive recordings. 
Limitations 
Data were acquired at 2 different institutions, under different clinical therapies (PVI and driver-
guided ablation) and with demographic differences. However, the correlation between body 
surface mapping and intracardiac mapping were consistent and seen across different types of AF 
patients: paroxysmal, persistent, long-standing and valvular AF. However, long-term clinical 
results of ablation in these patients are not yet available. Although AF termination is not 
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endpoint for persistent AF, and may provide an indication of AF mapping while long-term 
outcomes which can be influenced by long-term lesion recovery, drug adherence and AF 
progression. We did not include long-term outcomes as AF patients were recruited for different 
ablation protocols and their outcomes could not be consistently linked with the mapping 
approach. Performing DCCV and then reinducing AF may introduce additional variability into 
AF, since the precise relationship between the physiology of spontaneous and induced AF is 
undefined.  We have reported that AF drivers can be present for prolonged periods of time, 
although they certainly fluctuate32. 
Finally, we performed the body surface protocol with a reduced number of surface 
electrode set (57), which we have shown to be sufficient to reproduce the surface electrical 
activity during AF33-34 and is also more consistent with simultaneous intracardiac mapping from 
the ablation protocol.  
Conclusions 
Non-invasive characterization of AF complexity is feasible and accurately identifies reentrant 
activity identified on simultaneous panoramic contact mapping, including sites where ablation 
terminated AF.  While individual comparison of body surface and intracardiac reentrant drivers 
showed reasonably good correspondence, overall reentrant activity was well correlated which 
allows non-invasive metrics to accurately phenotype AF complexity. These body surface 
complexity measures were also correlated with acute ablation outcomes.  This opens the 
possibility of using body surface technology to non-invasively characterize AF and therefore 
personalize therapies better than existing clinical labels. 
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N 47 17 30 - 
Paroxysmal AF (%) 20 (43%) 3 (18%) 17 (57%) 0.009 
Male (%) 21 (45%) 14 (82%) 7 (23%) < 0.001 
Age (years) 63 ± 13 67 ± 9 61 ± 14 0.13 
AF history (months) 55 ± 56 85 ± 70 36 ± 32 0.01 
Previous ablations 1.1 ± 0.9 0.6 ± 1.0 1.4 ± 0.8 0.004 
Valvuloplasty 13 (28%) 0 (0%) 13 (43%) 0.001 












Figure1. Schematic view of the experiment set-up. A. Atrial anatomy (red) with 2 basket 
catheters in left (blue) and right (black) atria. B. Atrial anatomy segmentation from CT scan. C. 
Surface ECG electrode distribution. D. 3D meshes of the CT torso (purple), photogrammetry 
torso (green), atrial anatomy (red) and surface electrodes (pink). 
 
Figure  2. Localized reentry in AF co-localizes between intracardiac and body surface maps. A. 
Phase distribution from the intracardiac signals with reentry marked. Atrial anatomy is depicted 
in transparent gray. B. Activation sequence verifies reentry on intracardiac signals at the marked 
basket positions. C. Phase distribution from the inverse-computed signals at precisely the same 
time point as A, showing reentry in the free wall of the right atrium. D. Activation sequence is 
also shown from inverse-computed signals at the marked atrial positions. Voltage signals in blue 
and Phase transform in gray. Ic-EGM: inverse-computed EGM. 
 
Figure 3. Comparison of intracardiac and body surface AF sources. A. Intracardiac basket-
reconstructed reentry distribution map from patient #26. B. Body surface reentry distribution 
map for same patient in A. C. Comparison of intracardiac vs body surface number of sources at 
basket-mapped regions. D. Body surface reentrant sources for 50% of patients with low and high 
number of intracardiac AF sources respectively. E. Intracardiac AF sources for 50% of patients 
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Figure 4. Local comparison of intracardiac and body surface reentrant activity. A. Body surface 
Phase Singularity density at the intracardially-detected source regions vs at the rest of atrial 
anatomy mapped. B. Body surface stable rotor density at the intracardially-detected source 
regions vs in remaining mapped atrial anatomy.   
 
Figure 5. Body surface mapping in termination and non-termination patients. Body surface rotor 
map from a patient in which driver-guided ablation acutely terminated (A) or did not terminate 
AF (B).  
 
Figure 6. body surface reentry measures in patients under driver-guided ablation. A. Number of 
body surface AF sources for termination and non-termination patients. B. Number of body 
surface sources for paroxysmal and persistent patients. C. Proportion of paroxysmal and 
persistent AF patients in termination and non-termination groups.  
 
Figure 7. Rotors localized outside intracardiac mapped regions. A. Area covered by the basket 
catheter in a patient in whom driver-guided ablation did not terminate AF. B. Body surface AF 
source map for the patient in A, showing potential driver outside region mapped by baskets. C. 
Number of body surface sources outside the intracardially-mapped regions (brown in panel A) in 
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What is Known: 
• Phenotyping atrial fibrillation (AF) related with the response to therapy can improve the 
efficacy of current therapies.  
 
What the Study Adds: 
• Complexity, defined as the number of stable AF reentrant sites, can be an effective 
marker of AF phenotype and can be measured by non-invasive mapping of electrical 
patterns of disorganization and regions of reentrant activity. 
• AF complexity tracked non-invasively correlates well with organized and disorganized 
regions detected by panoramic intracardiac mapping,  
• Patients with lower AF complexity by non-invasive reentry measures correlates with 
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